Related references
Note: Only part of the references are listed.Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
Michel Delforge et al.
LANCET ONCOLOGY (2010)
Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma
A. Palumbo et al.
LEUKEMIA (2010)
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone
H. Avet-Loiseau et al.
LEUKEMIA (2010)
Proteins Required for Centrosome Clustering in Cancer Cells
Blanka Leber et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Inhibiting Crm1 causes the formation of excess acentriolar spindle poles containing NuMA and B23, but does not affect centrosome numbers
Annie Rousselet
BIOLOGY OF THE CELL (2009)
A mechanism linking extra centrosomes to chromosomal instability
Neil J. Ganem et al.
NATURE (2009)
Rapid antibody selection by mRNA display on a microfluidic chip
Noriko Tabata et al.
NUCLEIC ACIDS RESEARCH (2009)
Nucleophosmin is required for chromosome congression, proper mitotic spindle formation, and kinetochore-microtubule attachment in HeLa cells
Mohammed Abdullahel Amin et al.
FEBS LETTERS (2008)
NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells
W. Qi et al.
ONCOGENE (2008)
Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation
Zhaoliang Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein
Mitsuru Okuwaki
JOURNAL OF BIOCHEMISTRY (2008)
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Teru Hideshima et al.
NATURE REVIEWS CANCER (2007)
Antiproliferative and apoptosis inducing properties of pyrano[3,2-c]pyridones accessible by a one-step multicomponent synthesis
Igor V. Magedov et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen
Blanka Rebacz et al.
CANCER RESEARCH (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
Angela Dispenzieri et al.
BLOOD (2007)
Prognostic and therapeutic significance of myeloma genetics and gene expression profiling
AK Stewart et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication
W Wang et al.
NATURE CELL BIOLOGY (2005)
p53 deficiency exacerbates pleiotropic mitotic defects, changes in nuclearity and polyploidy in transdifferentiating pancreatic acinar cells
N Sphyris et al.
ONCOGENE (2005)
Cancer incidence and mortality in Europe, 2004
P Boyle et al.
ANNALS OF ONCOLOGY (2005)
Centrosomal amplification and spindle multipolarity in cancer cells
W Saunders
SEMINARS IN CANCER BIOLOGY (2005)
Tubulin-polymerization inhibitors derived from thalidomide
S Inatsuki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Spindle multipolarity is prevented by centrosomal clustering
NJ Quintyne et al.
SCIENCE (2005)
Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation
S Kurki et al.
CANCER CELL (2004)
In vitro selection of Jun-associated proteins using mRNA display
K Horisawa et al.
NUCLEIC ACIDS RESEARCH (2004)
Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses
CP Rubbi et al.
EMBO JOURNAL (2003)
Highly stable and efficient mRNA templates for mRNA-protein fusions and C-terminally labeled proteins
E Miyamoto-Sato et al.
NUCLEIC ACIDS RESEARCH (2003)
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
CS Debes-Marun et al.
LEUKEMIA (2003)
The role of nucleophosmin in centrosome duplication
M Okuda
ONCOGENE (2002)
Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma
ABT Fassas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Nucleophosmin regulates the stability and transcriptional activity of p53
E Colombo et al.
NATURE CELL BIOLOGY (2002)
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
N Mitsiades et al.
BLOOD (2002)
Hypodiploidy is a major prognostic factor in multiple myeloma
NV Smadja et al.
BLOOD (2001)